Thomas MitchellMEng DPhil BMBCh FRCS
Cancer Research UK/ Royal College of Surgeons Clinician Scientist Fellow and Honorary Consultant Urologist

Tom Mitchell is an Honorary Consultant with expertise in the surgical management of kidney cancer. His research focusses on gaining a detailed understanding of how kidney cancers initiate, evolve and resist treatment.
He was appointed Honorary Consultant at Addenbrooke’s Hospital after being awarded a Cancer Research UK/ Royal College of Surgeons Clinician Scientist Fellowship in October 2017.
Selected publications:
- Matthew D Young*, Thomas J Mitchell*, et al. Single cell transcriptomes from human kidneys reveal the identity of renal cancer cells. Science, 2018. *Joint first author.
- Thomas J Mitchell et al. Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal. Cell. 2018.
- David C. Wedge*, Gunes Gundem*, Thomas Mitchell*, et al. Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets. Nature Genetics, 2018. *Joint first author.